• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of endoscopic and pathological features of 6961 cases of gastric cancer.分析 6961 例胃癌的内镜和病理特征。
Sci Rep. 2024 Mar 26;14(1):7159. doi: 10.1038/s41598-024-58018-6.
2
Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.幽门螺杆菌感染的消化性溃疡患者中胃癌的特征。
World J Gastroenterol. 2015 Apr 28;21(16):4954-60. doi: 10.3748/wjg.v21.i16.4954.
3
Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.幽门螺杆菌根除对胃癌远端胃切除术后长期生存的影响。
Cancer Res Treat. 2016 Jul;48(3):1020-9. doi: 10.4143/crt.2015.264. Epub 2015 Nov 17.
4
Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer.幽门螺杆菌在贲门癌高发地区居民胃炎和贲门炎模式中的关键作用。
Dig Dis Sci. 2008 Jan;53(1):27-33. doi: 10.1007/s10620-007-9817-1. Epub 2007 May 10.
5
Gastric Xanthoma Is a Predictive Marker for Early Gastric Cancer Detected after Helicobacter pylori Eradication.胃黄色瘤是幽门螺杆菌根除后检测到的早期胃癌的预测标志物。
Intern Med. 2019 Mar 15;58(6):779-784. doi: 10.2169/internalmedicine.0925-18. Epub 2018 Nov 19.
6
Comparison between Resectable Helicobacter pylori-Negative and -Positive Gastric Cancers.可切除的幽门螺杆菌阴性与阳性胃癌的比较
Gut Liver. 2016 Mar;10(2):212-9. doi: 10.5009/gnl14416.
7
Intestinal metaplasia of the gastric cardia: a study from Turkey.贲门肠化生:一项来自土耳其的研究。
Hepatogastroenterology. 2002 Jul-Aug;49(46):1153-6.
8
Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori.胃癌的组织学亚型、位置与幽门螺杆菌之间的关系。
Scand J Gastroenterol. 1997 Apr;32(4):303-7. doi: 10.3109/00365529709007676.
9
Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology.血清抗幽门螺杆菌 IgG 抗体滴度高的非贲门胃癌的特征及其与弥漫型组织学的关系。
PLoS One. 2018 Apr 5;13(4):e0195264. doi: 10.1371/journal.pone.0195264. eCollection 2018.
10
Helicobacter pylori genotypes determine risk of non-cardia gastric cancer and intestinal- or diffuse-type GC in Ardabil: A very high-risk area in Northwestern Iran.幽门螺杆菌基因型决定了阿尔达比勒非贲门胃癌以及肠型或弥漫型胃癌的风险:伊朗西北部的一个极高风险地区。
Microb Pathog. 2017 Jun;107:287-292. doi: 10.1016/j.micpath.2017.04.007. Epub 2017 Apr 5.

引用本文的文献

1
Comparison of clinical and pathological characteristics between early gastric cardiac cancer and early gastric non-cardiac cancer.早期贲门胃癌与早期非贲门胃癌的临床及病理特征比较
Front Oncol. 2025 Jul 22;15:1513011. doi: 10.3389/fonc.2025.1513011. eCollection 2025.
2
Machine learning-based reconstruction of prognostic staging for gastric cancer patients with different differentiation grades: A multicenter retrospective study.基于机器学习的不同分化程度胃癌患者预后分期重建:一项多中心回顾性研究。
World J Gastroenterol. 2025 Apr 7;31(13):104466. doi: 10.3748/wjg.v31.i13.104466.
3
Investigating the causal association between serum uric acid levels and gastric cancer risk: a Mendelian randomization study.探讨血清尿酸水平与胃癌风险之间的因果关联:一项孟德尔随机化研究。
Sci Rep. 2024 Oct 30;14(1):26165. doi: 10.1038/s41598-024-77788-7.
4
From guidelines to radiology practice: navigating the 2023 ASCO guidelines for advanced gastroesophageal cancer and beyond.从指南到放射学实践:解读2023年美国临床肿瘤学会晚期胃食管癌及其他相关疾病指南
Abdom Radiol (NY). 2025 Jan;50(1):78-93. doi: 10.1007/s00261-024-04499-y. Epub 2024 Aug 9.

本文引用的文献

1
Evaluation of the detection rate of high‑grade gastric intraepithelial neoplasia using linked color imaging and white light imaging.使用联动彩色成像和白光成像评估高级别胃上皮内瘤变的检出率
Exp Ther Med. 2023 Jan 24;25(3):107. doi: 10.3892/etm.2023.11806. eCollection 2023 Mar.
2
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.胃癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2022 Oct;33(10):1005-1020. doi: 10.1016/j.annonc.2022.07.004. Epub 2022 Jul 29.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Abdominal Drainage in the Prevention and Management of Major Intra-Abdominal Complications after Total Gastrectomy for Gastric Carcinoma.胃癌全胃切除术后腹腔引流在预防和处理严重腹腔内并发症中的应用
J Gastric Cancer. 2020 Dec;20(4):376-384. doi: 10.5230/jgc.2020.20.e32. Epub 2020 Nov 11.
5
Gastroenterologists' attitudes on the detection and management of gastric premalignant conditions: results of a nationwide survey in Spain.西班牙全国性调查:胃肠病学家对胃前恶性病变的检测和处理的态度。
Eur J Cancer Prev. 2021 Nov 1;30(6):431-436. doi: 10.1097/CEJ.0000000000000648.
6
Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP.低发地区胃癌筛查:AEG、SEED 和 SEAP 的立场声明。
Gastroenterol Hepatol. 2021 Jan;44(1):67-86. doi: 10.1016/j.gastrohep.2020.08.004. Epub 2020 Oct 24.
7
Gastric cancer.胃癌。
Lancet. 2020 Aug 29;396(10251):635-648. doi: 10.1016/S0140-6736(20)31288-5.
8
Determinant Factors on Differences in Survival for Gastric Cancer Between the United States and Japan Using Nationwide Databases.基于国家数据库探讨美国和日本胃癌患者生存差异的决定因素。
J Epidemiol. 2021 Apr 5;31(4):241-248. doi: 10.2188/jea.JE20190351. Epub 2020 Apr 11.
9
Association of ABO Blood Groups and Risk of Gastric Cancer.ABO 血型与胃癌风险的关联。
Scand J Surg. 2020 Dec;109(4):309-313. doi: 10.1177/1457496919863886. Epub 2019 Jul 7.
10
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.英国胃肠病学会关于胃腺癌风险患者的诊断和管理指南。
Gut. 2019 Sep;68(9):1545-1575. doi: 10.1136/gutjnl-2018-318126. Epub 2019 Jul 5.

分析 6961 例胃癌的内镜和病理特征。

Analysis of endoscopic and pathological features of 6961 cases of gastric cancer.

机构信息

Faculty of Graduate Studies, Shanxi Medical University, Taiyuan City, 030000, Shanxi Province, China.

Department of Gastroenterology, First Hospital of Shanxi Medical University, Jie Fang South Road No.85, Taiyuan City, 030000, Shanxi Province, China.

出版信息

Sci Rep. 2024 Mar 26;14(1):7159. doi: 10.1038/s41598-024-58018-6.

DOI:10.1038/s41598-024-58018-6
PMID:38532198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10965891/
Abstract

Gastric cancer (GC) stage and tissue differentiation affect treatment efficacy and prognosis, highlighting the importance of understanding the risk factors that affect these parameters. Therefore, this study analyzed risk factors affecting the GC stage and differentiation and the relationships between the cancer site and the sex and age of the patient. We collected clinical data from 6961 patients with GC, including sex, age, endoscopic lesion location, and pathological differentiation. Patients were grouped based on GC stage (early or advanced), differentiation (well or poorly differentiated), and lesion site (upper stomach [cardia and fundus], middle stomach [gastric body], and lower stomach [gastric antrum]). Differences in sex, age, location, stage, and degree of differentiation were assessed based on these groupings. Univariate analysis revealed that the disease location and differentiation significantly differed based on the GC stage (P < 0.05), whereas sex, age, site, and stage significantly differed based on GC differentiation (P < 0.05). A multivariate analysis confirmed these factors as independent risk factors affecting GC. Moreover, lesion sites significantly differed between sexes (P < 0.05) and among age groups (P < 0.05). Although the effects of family history, lifestyle, and Helicobacter pylori infection status of the patients were not considered, this single-center retrospective study established independent risk factors for GC.Trial registration ChiCTR2200061989.

摘要

胃癌(GC)的分期和组织分化影响治疗效果和预后,这凸显了了解影响这些参数的危险因素的重要性。因此,本研究分析了影响 GC 分期和分化的危险因素,以及癌症部位与患者性别和年龄之间的关系。我们收集了 6961 例 GC 患者的临床资料,包括性别、年龄、内镜病变部位和病理分化。根据 GC 分期(早期或晚期)、分化(高分化或低分化)和病变部位(上胃[贲门和胃底]、中胃[胃体]和下胃[胃窦])对患者进行分组。根据这些分组评估了性别、年龄、部位、分期和分化程度的差异。单因素分析显示,疾病部位和分化与 GC 分期显著相关(P<0.05),而性别、年龄、部位和分期与 GC 分化显著相关(P<0.05)。多因素分析证实了这些因素是影响 GC 的独立危险因素。此外,病变部位在性别之间(P<0.05)和年龄组之间(P<0.05)存在显著差异。尽管未考虑患者的家族史、生活方式和幽门螺杆菌感染状况的影响,但这项单中心回顾性研究确定了 GC 的独立危险因素。试验注册 ChiCTR2200061989。